Parasol Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$5K Sell
100
-3,750
-97% -$206K 0.01% 89
2016
Q4
$225K Buy
3,850
+480
+14% +$26.2K 0.24% 57
2016
Q3
$182K Hold
3,370
0.19% 66
2016
Q2
$248K Hold
3,370
0.26% 55
2016
Q1
$215K Buy
3,370
+185
+6% +$11.7K 0.21% 53
2015
Q4
$219K Hold
3,185
0.21% 49
2015
Q3
$189K Hold
3,185
0.17% 54
2015
Q2
$212K Hold
3,185
0.14% 60
2015
Q1
$205K Hold
3,185
0.13% 59
2014
Q4
$188K Hold
3,185
0.13% 63
2014
Q3
$163K Buy
3,185
+185
+6% +$9.24K 0.11% 60
2014
Q2
$146K Buy
+3,000
New +$148K 0.1% 62

Other funds holding BMY

Parasol Investment Management's BMY Position: Q1 2017 in Review

Parasol Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 97% in Q1 2017, selling an estimated $206K and leaving 100 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #89.

Parasol Investment Management first reported a position in BMY in Q2 2014 and has held it in 12 quarters since. The position peaked at $248K in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • Parasol Investment Management held 100 shares of Bristol-Myers Squibb worth $5K as of Q1 2017.
  • Parasol Investment Management sold 3,750 Bristol-Myers Squibb shares in Q1 2017, an estimated $206K.
  • Bristol-Myers Squibb made up 0.01% of Parasol Investment Management's portfolio in Q1 2017, its #89 holding.
  • Parasol Investment Management first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 12 quarters since.
  • Parasol Investment Management's Bristol-Myers Squibb position peaked at $248K in Q2 2016.
  • 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on Parasol Investment Management's 13F filing for Q1 2017, filed 24 Apr 2017.